1. TCRP1 expression is associated with platinum sensitivity in human lung and ovarian cancer cells
    Xiaorong Liu et al, 2017 CrossRef
  2. DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients—A pilot study
    Ane Sørlie Kværner et al, 2018, DNA Repair CrossRef
  3. Genetic Instability in Peripheral Lymphocytes as Biological Marker for Non-Small Cell Lung Cancer Patients in the South Indian State of Andhra Pradesh
    Vidyullatha Peddireddy et al, 2014, The International Journal of Biological Markers CrossRef
  4. Comet assay and its use for evaluating oxidative DNA damage in some pathological states
    M. Kuchařová et al, 2019, Physiol Res CrossRef
  5. DNA damage and repair measured by comet assay in cancer patients
    Pavel Vodicka et al, 2019, Mutation Research/Genetic Toxicology and Environmental Mutagenesis CrossRef
  6. Mechanisms of Uptake and Interaction of Platinum Based Drugs in Eukaryotic Cells
    Lukas Nejdl et al, 2015 CrossRef
  7. Measurement of DNA damage with the comet assay in high-prevalence diseases: current status and future directions
    Peter Møller et al, 2019 CrossRef
  8. Genotoxic potential of selected cytostatic drugs in human and zebrafish cells
    Goran Gajski et al, 2016, Environ Sci Pollut Res CrossRef
  9. Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
    Marianna Macerelli et al, 2016, Cancer Treatment Reviews CrossRef
  10. Does Neuraxial Anesthesia as General Anesthesia Damage DNA? A Pilot Study in Patients Undergoing Orthopedic Traumatological Surgery
    Monika Kucharova et al, 2019, IJMS CrossRef
  11. An optimized comet-based in vitro DNA repair assay to assess base and nucleotide excision repair activity
    Sona Vodenkova et al, 2020, Nat Protoc CrossRef
  12. B-Comet Assay (Comet Assay on Buccal Cells) for the Evaluation of Primary DNA Damage in Human Biomonitoring Studies
    Carla Russo et al, 2020, IJERPH CrossRef
  13. The DNA damage response network in the treatment of head and neck squamous cell carcinoma
    A. Psyrri et al, 2021, ESMO Open CrossRef
  14. Damage to lymfocyte DNA during anaesthesia: a pilot study comparing general and subarachnoid anaesthesia
    D. Astapenko et al, 2020, Anest. intenziv. Med. CrossRef
  15. DNA damage in peripheral blood mononuclear cells in patients with melanoma
    E. V. Tsyrlina et al, 2022, Sib. onkol. ž. CrossRef
  16. The Comet Assay: A Versatile Tool for Assessing DNA Damage
    Mahima Bajpayee et al, 2016 CrossRef
  17. Comet assay
    Solange Costa et al, 2023 CrossRef
  18. DNA base oxidation in relation to TNM stages and chemotherapy treatment in colorectal cancer patients 2–9 months post-surgery
    Anne Lene Nordengen et al, 2023, Free Radical Biology and Medicine CrossRef
  19. Optimizing the Comet Assay-Based In Vitro DNA Repair Assay for Placental Tissue: A Pilot Study with Pre-Eclamptic Patients
    Anastasiya Mircheva et al, 2023, IJMS CrossRef
  20. Measurement of chromosomal instability and level of DNA damage in peripheral blood mononuclear cells of endometrial cancer patients
    Aleksandra Marković et al, 2024 CrossRef
  21. DNA Damage Response Network and Intracellular Redox Status in the Clinical Outcome of Patients with Lung Cancer
    Dimitra Mavroeidi et al, 2024, Cancers CrossRef